Navigation Links
Gamma Pharmaceuticals, Inc. Announces Key Appointment in Sales and Marketing
Date:3/7/2012

ST. PAUL, Minn., March 7, 2012 /PRNewswire/ -- Gamma Pharmaceuticals, Inc. (NASDAQ: GMPM.PK) announced today, that Bruce Renick, a senior industry insider, has agreed to join Gamma, initially on the Board of Advisors, later as fulltime Executive Vice President of Sales, once resources permit.  Bruce Renick was most recently the Executive Vice President of Global Sales and Marketing for TwinLab, one of the world's largest vitamin and nutraceutical companies.  At TwinLab, Bruce launched multiple product lines and line extensions and increased margins by revenue stream across product categories. 

Bruce is assisting management to develop and later to drive a more comprehensive sales plan, creating a timeline for product launches and growing the internal functions to make Gamma Pharmaceuticals an industry leader of cutting-edge delivery system technologies in the supplement category. 

Gamma's President, Joe Cunningham commented, "We are happy that Bruce has agreed to join Gamma.  Last autumn, we changed management positions to put more focus on making sales.  If we were missing one person in our management team, it was a true industry sales professional, an experienced insider with retail contacts who can close a sale and execute.  Bruce is that guy." 

About Gamma Pharmaceuticals, Inc.

Gamma Pharmaceuticals, Inc., (www.gammapharma.com) is a marketing and product formulation company selling its own branded products through wholesalers and direct to retailers, both in the US and internationally.  Gamma's core focus is the marketing and sale of vitamins and nutriceuticals, OTC pharmaceutical products and personal care products in the United States.   Branded nutritional supplements are sold under the trademarks Brilliant Choice™ nutritional supplements featuring the call to action "You've made a brilliant choice for your nutrition;" SAVVY™ adult nutritional supplements featuring the call to action, "Be SAVVY Stay Healthy;" and, Gamma Energy Products™ a high performance supplement featuring the call to action, "Get Your Gamma On."  Gamma's customer focus is on selling products in the Lifestyle of Health & Sustainability ("LOHAS") marketplace and in the Energy Supplement Market.  A series of innovative marketing programs support Gamma's product sales and retail partners.  

At present Gamma manufactures in North America, and distributes in the United States. Gamma's products utilize proprietary "Gel Delivery Technology®", to create innovative gel product forms that give consumers a more pleasant experience.  Gel Delivery Technology® characteristics include rapid absorption, convenience and great taste.  Market categories Gamma targets are growing as rapidly as 60% per year.  Gamma has developed formulas and strategies for Metabolic Syndrome and Diabetes Type II, Stress Reduction, Cognition, Well-being, Menopause Symptoms and Personal Care Products. Gamma also develops and manufactures house brands for major retailers.  At this time, Gamma has a total of 36 SKU's and holds licenses for 9 SKUs in China.

Forward-Looking Statements: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this Press Release regarding any impact the quotation of the Company's stock has on the Pink Sheets or the lack thereof on the OTCBB, and any other effects of the above are forward-looking statements. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

Contact: Gamma Pharmaceuticals, Inc.
Joe Cunningham, President (jcunningham@gammapharma.com)
Direct:  (651) 204 2048


'/>"/>
SOURCE Gamma Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Baxter and The Alzheimers Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimers Disease
2. Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia
3. Elekta Announces Clinical Start-Up of New Leksell Gamma Knife(R) Perfexion(TM) at UPMC
4. Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics
5. FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
6. Baxter Presents Latest Clinical Trial Results of GAMMAGARD LIQUID Administered Subcutaneously
7. Study Results of GAMMAGARD S/D and GAMMAGARD LIQUID in Patients with Mild-to-Moderate Alzheimers Disease Announced
8. Community Breast Center Experience Shows Real-World Application of Breast-Specific Gamma Imaging Has Significant Impact on Clinical Care
9. European Unions CHMP Issues Positive Opinion on Sugammadex
10. BRIDION(R) (sugammadex) Injection - First and Only Selective Relaxant Binding Agent - Approved in European Union
11. U.S. FDA Issues Action Letter for Sugammadex
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2017)... -- Just 18 months after its February 2016 launch, market ... appointment of three new senior people to its rapidly ... and James Wright bring decades of ... Tammy Wynne joins as Director, Value ... has over ten years, experience in global market access ...
(Date:8/31/2017)... PM360,s annual Innovations Issue, published in ... innovations happening across the industry. Established six years ago, ... providing a comprehensive look at the newest and most ... innovative companies, startups, divisions, products, services, and strategies from ... "Everyone in this industry wants to do better—in all ...
(Date:8/25/2017)... -- Innovation Zed ( www.innovationzed.com ), an Irish medtech company, today announced that ... and Bassetlaw, England . The ... as part of a national NHS Test Bed programme exploring new models ... Innovation Zed ... InsulCheck Connect, a snap-on accessory for disposable insulin pen users, automatically collects ...
Breaking Medicine Technology:
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... ... with offices serving communities in northern Alabama and Georgia, is embarking on an ... prevention by utilizing modern early detection methods. , US Breast Cancer statistics ...
(Date:9/20/2017)... ... September 20, 2017 , ... Collins Concrete Coatings announced that ... rely on safety and cleanliness. This unique flooring system uses silver ion technology ... for centuries for its antimicrobial properties. Unlike antibiotics, which kill specific microorganisms, silver ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... company specializing in medical device compliance and commercialization, has just released a ... activities. , FDA is more adamant than ever about medical device, pharmaceutical, ...
(Date:9/20/2017)... Cleveland, Ohio (PRWEB) , ... September 20, 2017 ... ... commitment to customer service and innovation, the company recently unveiled a redesigned website. ... to further enrich the work of building owners, architects, contractors and other industry ...
(Date:9/20/2017)... ... September 20, 2017 , ... The Honey Pot Company is ... goal is to ignite conversation via social media and word-of-mouth regarding vaginal health, ... declared September “Humans with Vaginas” month, releasing a video celebrating the power of ...
Breaking Medicine News(10 mins):